Gene Therapy for Achromatopsia (CNGB3)
Clinical trial NCT03001310 · COMPLETED
Trial details
- NCT number
- NCT03001310
- Sponsor
- MeiraGTx UK II Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-16
- Primary completion
- 2019-10-25
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.